Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;3(1):e2011050.
doi: 10.4084/MJHID.2011.050. Epub 2011 Oct 26.

Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response

L Nosotti  1 , T D'Arca, M Marignani, G Balducci
Affiliations

Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response

L Nosotti et al. Mediterr J Hematol Infect Dis. 2011.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Granito A, Bolondi L. Medical treatment of hepatocellular carcinoma. Mediterr J Hematol Infect Dis. 2009 Dec 16;1(3):e2009021. doi: 10.4084/MJHID.2011.021. - DOI - PMC - PubMed
    1. Kasahara A, Hayashi N, Mochizuki K, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998;27:1394–1402. doi: 10.1002/hep.510270529. - DOI - PubMed
    1. Kobayashi S, Takeda T, Enomoto M, et al. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients. Liver Int. 2007;27:186–191. doi: 10.1111/j.1478-3231.2006.01406.x. - DOI - PubMed
    1. Tokita H, Fukui H, Tanaka A, et al. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol. 2005;20:752–758. doi: 10.1111/j.1440-1746.2005.03800.x. - DOI - PubMed
    1. Akamatsu M, Yoshida H, Shiina S, et al. Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma. Liver Int. 2006;26:536–542. doi: 10.1111/j.1478-3231.2006.01260.x. - DOI - PubMed